{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:45:58Z","timestamp":1794217558659,"version":"4.8.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572272"],"award-info":[{"award-number":["82572272"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203014"],"award-info":[{"award-number":["82203014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202306386"],"award-info":[{"award-number":["tsqn202306386"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH017"],"award-info":[{"award-number":["ZR2022QH017"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1499"],"award-info":[{"award-number":["ZR2025MS1499"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH023"],"award-info":[{"award-number":["ZR2024QH023"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M742149"],"award-info":[{"award-number":["2023M742149"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1053\/j.semnuclmed.2026.02.007","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:57:58Z","timestamp":1774933078000},"page":"719-735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["FAP in cardiovascular pathophysiology: Advances in non-invasive imaging and therapeutic targeting for myocardial fibrosis"],"prefix":"10.1053","volume":"56","author":[{"given":"Jinli","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0001","first-page":"10","article-title":"Cardiac Magnetic resonance imaging in heart failure","volume":"9","author":"Pan","year":"2024","journal-title":"Cardiovasc Innov Appl"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.02.007_bib0002","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/ehjci\/jead124","article-title":"Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review","volume":"24","author":"Pan","year":"2023","journal-title":"Eur heart j Cardiovasc Imaging"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0003","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jcmg.2019.01.026","article-title":"Multiparametric cardiac magnetic resonance imaging can detect acute cardiac allograft rejection after heart transplantation","volume":"12","author":"Dolan","year":"2019","journal-title":"J Am Coll Cardiol Img"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.007_bib0004","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11886-023-01869-8","article-title":"The potential of fibroblast activation protein-targeted imaging as a biomarker of cardiac remodeling and injury","volume":"25","author":"Mayola","year":"2023","journal-title":"Curr Cardiol Rep"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115914","article-title":"Fibroblast activation protein: pivoting cancer\/chemotherapeutic insight towards heart failure","volume":"219","author":"Gehris","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"13","key":"10.1053\/j.semnuclmed.2026.02.007_bib0006","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1007\/s00259-025-07385-x","article-title":"Fibroblast activation protein-targeted PET\/CT in multiple non-ischemic cardiomyopathies","volume":"52","author":"Yang","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"14","key":"10.1053\/j.semnuclmed.2026.02.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202411152","article-title":"Fibroblast activation protein acts as a biomarker for monitoring ECM remodeling during aortic aneurysm via (68)Ga-FAPI-04 PET imaging","volume":"12","author":"Hu","year":"2025","journal-title":"Adv Sci"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0008","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.124.268376","article-title":"Targeting fibroblast activation protein for molecular imaging of fibrotic remodeling in pulmonary arterial hypertension","volume":"66","author":"Hou","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101910","article-title":"(99m)Tc-HFAPi SPECT imaging predicts left ventricular remodeling after acute myocardial infarction","volume":"38","author":"Hua","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","article-title":"Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction","volume":"87","author":"Tillmanns","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.007_bib0011","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248196","article-title":"Genetic ablation of fibroblast activation protein alpha attenuates left ventricular dilation after myocardial infarction","volume":"16","author":"Hoffmann","year":"2021","journal-title":"PloS One"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09790-1","article-title":"Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction","volume":"7","author":"Nagaraju","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.007_bib0014","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.116.026238","article-title":"Fibroblast-specific genetic manipulation of p38 mitogen-activated protein kinase In vivo reveals its Central regulatory role in fibrosis","volume":"136","author":"Molkentin","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.02.007_bib0015","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/CIRCRESAHA.117.312130","article-title":"Endoplasmic reticulum protein TXNDC5 augments myocardial fibrosis by facilitating extracellular matrix protein folding and redox-sensitive cardiac fibroblast activation","volume":"122","author":"Shih","year":"2018","journal-title":"Circ Res"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.02.007_bib0016","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCRESAHA.116.309538","article-title":"Cardiac fibroblast GRK2 deletion enhances contractility and remodeling following ischemia\/reperfusion injury","volume":"119","author":"Woodall","year":"2016","journal-title":"Circ Res"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.02.007_bib0017","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jacc.2017.06.049","article-title":"Pharmacological and activated fibroblast targeting of g\u03b2\u03b3-GRK2 after myocardial ischemia attenuates heart failure progression","volume":"70","author":"Travers","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.02.007_bib0018","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/cells11091386","article-title":"Properties and functions of fibroblasts and myofibroblasts in myocardial infarction","volume":"11","author":"Venugopal","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.007_bib0019","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","article-title":"Myocardial fibroblast activation after acute Myocardial infarction: A positron emission tomography and magnetic resonance study","volume":"85","author":"Barton","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.02.007_bib0020","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s00259-021-05674-9","article-title":"Fibroblast activation protein imaging in reperfused ST-elevation myocardial infarction: comparison with cardiac magnetic resonance imaging","volume":"49","author":"Xie","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.02.007_bib0021","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/RLU.0000000000003745","article-title":"Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET","volume":"46","author":"Kessler","year":"2021","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.02.007_bib0022","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac fibroblast activation in patients early after acute myocardial infarction: integration with MR tissue characterization and subsequent functional outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.007_bib0023","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1007\/s12350-021-02603-z","article-title":"Imaging of cardiac fibroblast activation in a patient after acute myocardial infarction using (68)Ga-FAPI-04","volume":"29","author":"Notohamiprodjo","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"16","key":"10.1053\/j.semnuclmed.2026.02.007_bib0024","doi-asserted-by":"crossref","first-page":"7755","DOI":"10.7150\/thno.51419","article-title":"Molecular imaging of fibroblast activation protein after myocardial infarction using the novel radiotracer [(68)Ga]MHLL1","volume":"11","author":"Langer","year":"2021","journal-title":"Theranostics"},{"issue":"14","key":"10.1053\/j.semnuclmed.2026.02.007_bib0025","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2021.02.019","article-title":"Molecular imaging identifies fibroblast activation beyond the infarct region after acute myocardial infarction","volume":"77","author":"Diekmann","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.007_bib0026","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00259-022-06015-0","article-title":"(68)Ga]Ga-DOTA-FAPI-04 PET\/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70198","article-title":"Application of (68)Ga- and (177)Lu-labeled FAP inhibitor in evaluation and treatment of cardiac fibrosis after myocardial infarction","volume":"6","author":"Zhao","year":"2025","journal-title":"MedComm"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102106","article-title":"Cardiovascular positron emission tomography imaging of fibroblast activation: a review of the current literature","volume":"47","author":"Loganath","year":"2025","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0029","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11307-025-01994-6","article-title":"Spatial FAP expression as detected by (68) Ga-FAPI-46 identifies myofibroblasts beyond the infarct scar after reperfusion","volume":"27","author":"Hess","year":"2025","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0030","article-title":"Delayed (68)Ga-FAPI-46 PET\/MR imaging confirms ongoing fibroblast activation in patients after acute myocardial infarction","volume":"50","author":"Kupusovic","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.007_bib0031","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/ph18050658","article-title":"Molecular imaging of fibroblast activation protein in response to cardiac injury using [(68)Ga]Ga-DATA(5m).SA.FAPi","volume":"18","author":"Weissenb\u00f6ck","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"19","key":"10.1053\/j.semnuclmed.2026.02.007_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914845","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: A perspective from fibroblasts","volume":"24","author":"Schlittler","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1053\/j.semnuclmed.2026.02.007_bib0033","doi-asserted-by":"crossref","first-page":"ytae189","DOI":"10.1093\/ehjcr\/ytae189","article-title":"Tissue-level evidence of fibroblast activation protein inhibitor imaging in hypertrophic obstructive cardiomyopathy: a case series","volume":"8","author":"Li","year":"2024","journal-title":"Eur Heart J Case Rep"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221052","article-title":"Myocardial activity at (18)F-FAPI PET\/CT and risk for sudden cardiac death in hypertrophic cardiomyopathy","volume":"306","author":"Wang","year":"2023","journal-title":"Radiology"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.02.007_bib0035","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jcmg.2022.06.004","article-title":"Feasibility of (68)Ga-labeled fibroblast activation protein inhibitor PET\/CT in light-chain cardiac amyloidosis","volume":"15","author":"Wang","year":"2022","journal-title":"J Am Coll Cardiol Img"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0036","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00259-023-06411-0","article-title":"Functional significance of myocardial activity at (18)F-FAPI PET\/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis","volume":"51","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0037","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00259-024-06878-5","article-title":"Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [(68)Ga]Ga-FAPI-04 PET\/CMR imaging","volume":"52","author":"Ding","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0038","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"2","author":"Mori","year":"2024","journal-title":"Npj imaging"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.02.007_bib0039","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/cells13090752","article-title":"Single-cell RNA sequencing reveals cardiac fibroblast-specific transcriptomic changes in dilated cardiomyopathy","volume":"13","author":"Russell-Hallinan","year":"2024","journal-title":"Cells"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.02.007_bib0040","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.3390\/ijms25116004","article-title":"Fibroblast diversity and epigenetic regulation in cardiac fibrosis","volume":"25","author":"Aguado-Alvaro","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.007_bib0041","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s11427-023-2452-2","article-title":"Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathy","volume":"67","author":"Yuan","year":"2024","journal-title":"Sci China Life sci"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0042","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCRESAHA.120.317685","article-title":"Multiscale analysis of extracellular matrix remodeling in the failing heart","volume":"128","author":"Perestrelo","year":"2021","journal-title":"Circ Res"},{"issue":"9","key":"10.1053\/j.semnuclmed.2026.02.007_bib0043","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jcmg.2025.05.021","article-title":"Comparison of (18)F-FAPI-42 PET for detecting cardiac fibroblast activation in dilated cardiomyopathy with histopathology and CMR","volume":"18","author":"Liang","year":"2025","journal-title":"J Am Coll Cardiol Img"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.007_bib0044","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3390\/ph18040522","article-title":"Fibroblast activation protein inhibitor (FAPI)-based theranostics","volume":"18","author":"Serumula","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0045","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12350-020-02315-w","article-title":"Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography","volume":"29","author":"Shi","year":"2022","journal-title":"J Nucl Cardiol"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.02.007_bib0046","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.jcmg.2022.08.019","article-title":"Fibroblast activation: A novel mechanism of heart failure in light chain cardiac amyloidosis?","volume":"15","author":"Dorbala","year":"2022","journal-title":"J Am Coll Cardiol Img"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.007_bib0047","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcmg.2024.10.001","article-title":"Molecular stratification of light-chain cardiac amyloidosis with (18)F-florbetapir and (68)Ga-FAPI-04 for enhanced prognostic precision","volume":"18","author":"Wang","year":"2025","journal-title":"J Am Coll Cardiol Img"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.02.007_bib0048","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12149-019-01372-7","article-title":"Amyloid PET imaging in cardiac amyloidosis: a pilot study using (18)F-flutemetamol positron emission tomography","volume":"33","author":"Dietemann","year":"2019","journal-title":"Ann Nucl Med"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.02.007_bib0049","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11886-021-01506-2","article-title":"Potential cardiac amyloid PET\/CT imaging targets for differentiating immunoglobulin light chain from transthyretin amyloidosis","volume":"23","author":"Schindler","year":"2021","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11886-025-02230-x","article-title":"(68)Ga-FAPI-04 PET\/CT for the assessment of light-chain cardiac amyloidosis: A promising risk- stratification imaging modality","volume":"27","author":"Zheng","year":"2025","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0051","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12931-023-02565-5","article-title":"[(18) F] -FAPI-42 PET\/CT assessment of progressive right ventricle fibrosis under pressure overload","volume":"24","author":"Zeng","year":"2023","journal-title":"Respir Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0052","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00259-022-05984-6","article-title":"Molecular imaging of fibroblast activity in pressure overload heart failure using [(68)Ga]Ga-FAPI-04 PET\/CT","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0053","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12350-022-02952-3","article-title":"(68)Ga-FAPI PET\/CT for molecular assessment of fibroblast activation in right heart in pulmonary arterial hypertension: a single-center, pilot study","volume":"30","author":"Gu","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0054","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12880-025-01592-6","article-title":"Comparison of the value of FAPI imaging and speckle\u2011tracking echocardiography in assessment of right ventricular remodeling in pulmonary hypertension","volume":"25","author":"Chen","year":"2025","journal-title":"BMC Med Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.007_bib0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00259-021-05577-9","article-title":"Imaging of cardiac fibroblast activation in patients with chronic thromboembolic pulmonary hypertension","volume":"49","author":"Chen","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.007_bib0056","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s12350-022-03069-3","article-title":"Pulmonary artery imaging with (68) Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension","volume":"30","author":"Gong","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0057","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13550-023-00986-3","article-title":"Molecular imaging of fibroblast activation in multiple non-ischemic cardiomyopathies","volume":"13","author":"Wang","year":"2023","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2025.100624","article-title":"Simultaneous (18)F-labeled AlF-FAPI PET\/MR images targeting the myocardial fibrosis in coronary artery disease and degenerative mitral valve regurgitant participants with left ventricular mechanical dyssynchrony","volume":"80","author":"Chen","year":"2025","journal-title":"Clinics"},{"issue":"11","key":"10.1053\/j.semnuclmed.2026.02.007_bib0059","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/metabo14110573","article-title":"Immunohistochemical localization of fibroblast activation protein in coronary arteries with different forms of atherosclerosis","volume":"14","author":"Mohmand-Borkowski","year":"2024","journal-title":"Metabolites"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.007_bib0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s11307-024-01919-9","article-title":"Molecular imaging of fibroblast activation in rabbit atherosclerotic plaques: a preclinical PET\/CT study","volume":"26","author":"Ji","year":"2024","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2026.02.007_bib0061","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/cvr\/cvaa142","article-title":"Deletion of fibroblast activation protein provides atheroprotection","volume":"117","author":"Stein","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1053\/j.semnuclmed.2026.02.007_bib0062","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00259-023-06245-w","article-title":"Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors","volume":"50","author":"Kosmala","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1053\/j.semnuclmed.2026.02.007_bib0063","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2967\/jnumed.121.262863","article-title":"Feasibility of In vivo imaging of fibroblast activation protein in Human arterial walls","volume":"63","author":"Wu","year":"2022","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.007_bib0064","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s12350-020-02307-w","article-title":"Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury\/remodeling","volume":"28","author":"Siebermair","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0065","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00259-022-05962-y","article-title":"Early detection of radiation-induced myocardial damage by [(18)F]AlF-NOTA-FAPI-04 PET\/CT imaging","volume":"50","author":"Wei","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1053\/j.semnuclmed.2026.02.007_bib0066","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1007\/s00259-024-06673-2","article-title":"Early detection of anthracycline-induced cardiotoxicity using [(68) Ga]Ga-FAPI-04 imaging","volume":"51","author":"Wei","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.007_bib0067","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s11307-025-02005-4","article-title":"The imaging value of (18)F-FAPI PET\/CT in Sorafenib-induced cardiac dysfunction in patients with hepatocellular carcinoma: compared with (18)F-FDG PET\/CT","volume":"27","author":"Luo","year":"2025","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.614997","article-title":"Early detection of checkpoint inhibitor-associated myocarditis using (68)Ga-FAPI PET\/CT","volume":"8","author":"Finke","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2026.02.007_bib0069","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00259-022-06018-x","article-title":"Different displays of (13)N-NH(3) myocardial perfusion and cardiac (68)Ga-FAPI PET in immune checkpoint inhibitor-associated myocarditis-induced heart failure","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7774","key":"10.1053\/j.semnuclmed.2026.02.007_bib0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114760","article-title":"Fibroblast activation protein-targeted chimeric antigen-receptor-modified NK cells alleviate cardiac fibrosis","volume":"157","author":"Zheng","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0072","doi-asserted-by":"crossref","DOI":"10.1155\/cdr\/7230505","article-title":"Fibroblast activation protein-targeted CAR-T cells induce apoptosis in murine cardiac myofibroblasts","volume":"2025","author":"Li","year":"2025","journal-title":"Cardiovasc Ther"},{"issue":"7","key":"10.1053\/j.semnuclmed.2026.02.007_bib0073","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108587","article-title":"Novel insights in CAR-NK cells beyond CAR-T cell technology; promising advantages","volume":"106","author":"Ebrahimiyan","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114683","article-title":"Chimeric antigen receptor (CAR)-NK cell therapy in gastrointestinal (GI) cancers; a new arena","volume":"450","author":"Alkhathami","year":"2025","journal-title":"Exp Cell Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0076","article-title":"CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines","volume":"6","author":"Look","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1433679","article-title":"Efficacy and safety evaluation of cross-reactive fibroblast activation protein scFv-based CAR-T cells","volume":"15","author":"Niu","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2026.02.007_bib0078","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCRESAHA.124.325017","article-title":"A vaccine against fibroblast activation protein improves murine cardiac fibrosis by preventing the accumulation of myofibroblasts","volume":"136","author":"Yoshida","year":"2025","journal-title":"Circ Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2026.02.007_bib0079","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jcdd10020052","article-title":"Ciclopirox inhibition of eIF5A hypusination attenuates fibroblast activation and cardiac fibrosis","volume":"10","author":"Subbaiah","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1053\/j.semnuclmed.2026.02.007_bib0080","article-title":"Glycolysis inhibition alleviates cardiac fibrosis after myocardial infarction by suppressing cardiac fibroblast activation","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299826000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:31:26Z","timestamp":1792585886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299826000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0001299826000498"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.02.007","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FAP in cardiovascular pathophysiology: Advances in non-invasive imaging and therapeutic targeting for myocardial fibrosis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2026.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}